Form 4: Former HealthEquity Director Jon Kessler Executes Options and Sells Over 230,000 Shares

Former HealthEquity, Inc. director Jon Kessler reported exercising stock options and subsequently selling a significant number of common shares, both directly and indirectly through GKF, LLC, on June 6, 2025.

Summary

• Jon Kessler, identified as a former Director of HealthEquity, Inc. (HQY), reported multiple transactions on June 6, 2025.
• He directly acquired 79,681 shares of Common Stock through the exercise of stock options at prices ranging from $41.28 to $73.61 per share.
• Concurrently, he directly disposed of 134,183 shares of Common Stock through sales at weighted average prices ranging from $111.8368 to $112.7 per share.
• Indirectly, through GKF, LLC, he acquired 71,532 shares of Common Stock by exercising stock options at prices ranging from $41.28 to $73.61 per share.
• GKF, LLC also indirectly disposed of 97,767 shares of Common Stock through sales at weighted average prices ranging from $111.8347 to $113.35 per share.
• Following these transactions, Jon Kessler directly beneficially owns 253,510 shares of Common Stock and indirectly owns 75,000 shares through GKF, LLC.
• The total number of shares acquired through option exercises was 151,213, and the total number of shares sold was 231,950.

Sentiment

Score: 6

Explanation: The filing reports routine insider transactions involving the exercise of stock options and subsequent sale of shares, which is a common practice for former executives. While it represents insider selling, it's tied to option exercise and not necessarily indicative of negative sentiment towards the company's future, thus leaning slightly positive for the insider's personal gain.

Positives

• The exercise of stock options at significantly lower prices ($41.28 $73.61) and subsequent sale of shares at much higher market prices ($111.25 $113.36) indicates a profitable transaction for the reporting person.
• The transactions represent a routine liquidity event for a former executive, which is a common and expected practice.

Negatives

• The sale of a substantial number of shares by a former director, totaling 231,950 shares, could be perceived by some investors as a reduction in insider exposure, although it is tied to option exercises.

Future Outlook

NA

Industry Context

This Form 4 filing is a routine disclosure of insider transactions and does not provide information related to broader industry trends or competitive landscape for HealthEquity, Inc.

Related Party Transactions

• Shares are held indirectly by GKF, LLC, and the reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.

Stakeholder Impact

• Shareholders may note the insider selling activity, which is a common occurrence for former executives monetizing their equity compensation.

Key Dates

Keywords

HealthEquity, HQY, Jon Kessler, Form 4, Insider Trading, Stock Options, Share Sale, Beneficial Ownership, SEC Filing